Evidence map›Paper›PMID 30801048›Full record

ArticleJournal of neuropsychiatry (Foster City, Calif.)2018

Peripheral Cortisol and Inflammatory Response to a Psychosocial Stressor in People with Schizophrenia.

Matthew Glassman, Heidi J Wehring, Ana Pocivavsek, Kelli M Sullivan, Laura M Rowland, Robert P McMahon, Joshua Chiappelli, Fang Liu, Deanna L Kelly

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuropsychiatry (Foster City, Calif.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Cortisol and cytokines in schizophrenia: A scoping review.Comprehensive psychoneuroendocrinology · 2023
    Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Matthew GlassmanMaryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Heidi J WehringMaryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Ana PocivavsekMaryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Kelli M SullivanUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Laura M RowlandMaryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Robert P McMahonMaryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Joshua ChiappelliMaryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Fang LiuMaryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Deanna L KellyMaryland Psychiatric Research Center, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
University of Maryland, Baltimore · USUniversity of North Carolina at Chapel Hill · US

Funding

The Effects of Kynurenine Aminotransferase Inhibition in People with SchizophreniaP50MH103222 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI SCHWARCZ, ROBERT · 2014 to 2023
$25.2M
NIMH NIH HHS P50 MH103222
6 · The paper itself

Abstract

objectivesThere is growing evidence of both hypothalamic-pituitary-adrenal (HPA) axis and immune system dysfunction in schizophrenia. Additionally, accumulating evidence has linked dysfunction in the kynurenine pathway to schizophrenia as well as to stress and inflammation. The current pilot tested changes in immune, cortisol and kynurenine and kynurenic acid responses to a psychosocial stressor in people with schizophrenia and healthy controls.

methodsTen people with schizophrenia/schizoaffective disorder and 10 healthy controls were included. Participants completed the Trier Social Stress Test (TSST) and cortisol, cytokines (IL-6 & TNF-α), kynurenine and kynurenic acid were measured in the plasma at baseline 15, 30, 60 and 90 minutes following the TSST.

resultsCompared to baseline, at 30 minutes post TSST, mean cortisol levels had increased by 7.6 ng/ml (11%) in healthy controls but decreased by 16.3 ng/ml (25%) in schizophrenia (F=4.34, df=3,38.2, p=0.010). While people with schizophrenia had a lower TNF-α level at baseline (χ

conclusionPeople with schizophrenia showed a decrease in cortisol from baseline following the TSST as compared to an elevation from baseline seen in healthy controls, supporting HPA axis dysfunction in schizophrenia. An immediate inflammatory response with IL-6 was seen in both groups following the TSST. Larger studies should examine psychosocial stress response in schizophrenia and the relationship of immune function and kynurenine pathway.

Indexed as

CortisolInflammationKynurenic acidKynurenineSchizophreniaStressTNF-α

Identifiers

PMID30801048
PMCPMC6384221
OpenAlexW2898030345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.